What is it? Why is it important?

Upon study conduct, various analysis methods can be used to evaluate and interpret the study data.

 

The choice of the analysis method(s) depends on the study design, research objective(s), and the nature of the data (e.g. quantitative and numerical or qualitative and descriptive)

 

The analysis method(s) selected for assessing each study outcome, must be outlined in the study protocol, and, if applicable, in a Statistical Analysis Plan (SAP).

 

The adherence to pre-defined analyses methods is important as it ensures transparency, thus allowing other researchers to:

  • Retrace and understand how study results were obtained
  • Reproduce the analysis

 

Pre-defined analyses methods increase the credibility of study results. It avoids the implementation of post hoc decisions (i.e. decision that are made after seeing the data), thereby preventing:

  • The selective reporting of favourable results

A (conscious or unconscious) influence by the SP-INV on the data analysis in order to produce desirable outcomes

What do I need to do?

As a SP-INV, discuss and define together with a statistician the most appropriate analysis methods needed to assess study outcome(s)/endpoint(s).

 

Note:

Apart from outlining the analysis method in the study protocol, a Statistical Analysis Plan (SAP) is usually suggested in more complex studies. These studies require more in depth explanations regarding the statistical aspects of a study (e.g. multi-centre studies, placebo and comparator studies, blinded studies, the inclusion of interim analyses)

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

References

ICH Topic E9 – see in particular

  • 5.1 Prespecification of the analysis
Abbreviations
  • CTU – Clinical Trials Unit
  • ICH – International Council for Harmonisation
  • SAP – Statistical Analysis Plan
  • SP-INV – Sponsor Investigator
Development ↦ Statistic Methodology ↦ Statistics in the Protocol ↦ Analysis Method
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Development ↦ Statistic Methodology ↦ Statistics in the Protocol ↦ Analysis Method

Please note: the Easy-GCS tool is currently under construction.